(Health-NewsWire.Net, November 02, 2016 ) According to Publisher, the Global Diabetic Retinopathy Treatment market is expected to reach $10.24 billion by 2022. Rising prevalence of diabetics, increasing management financial support, change in lifestyle and global aging population are the factors driving the market growth. However, Lack of accurate diagnosis, a lack of skilled ophthalmologist coupled with poor infrastructure and extended approval time for drugs are hampering the growth of global Diabetic Retinopathy Market. Increase in awareness of diabetic retinopathy treatment and improvement of patient monitoring are some of the major trends in the market. The two main stages of diabetic retinopathy are non-proliferated and proliferated. Proliferated diabetic retinopathy is the mainly insecure stage and has the risk of detachment into the vitreous leading to severe vision loss.
Report URL: http://www.reportsweb.com/diabetic-retinopathy-treatment-global-market-outlook-2015-2022 North America leads the global diabetic retinopathy market due to vast number of aging population. The Asia Pacific diabetic retinopathy market is expected to witness profitable growth over the estimated period due to the occurrence of unmet needs in the developing countries such as China and India. These countries are expected to be the fastest growing diabetic retinopathy markets in Asia-Pacific region.
Some of the key players in the market include Regeneron Pharmaceuticals Inc., ThromboGenics, Genentech, Bayer Healthcare, Alimera Sciences, Actavis PLC, BCN Peptides, Novartis AG, Ampio Pharmaceuticals, Kowa Group, Sirnaomics Incorporation, Abbott Laboratories Ltd, Glycadia Pharmaceuticals, Alcon Laboratories Inc. and Parexel International Corp.
Type of Treatments Covered: - Intraocular Steroid Injection - Vitrectomy - Anti-Vascular Endothelial Growth Factor (VEGF) drug - Laser Surgery
Disease Type Covered: - Proliferative Diabetic Retinopathy (PDR) - Non-Proliferative Diabetic Retinopathy (NPDR) - Moderate - Mild - Severe
Request for Sample @ http://www.reportsweb.com/inquiry&RW0001216339/sample End Users Covered: - Ophthalmic Clinics - Ambulatory Surgical Centers - Hospitals - Other End Users
Regions Covered: - North America - US - Canada - Mexico - Europe - Germany - France - Italy - UK - Spain - Rest of Europe - Asia Pacific - Japan - China - India - Australia - New Zealand - Rest of Asia Pacific - Rest of the World - Middle East - Brazil - Argentina - South Africa - Egypt
Inquire for Discount @ http://www.reportsweb.com/inquiry&RW0001216339/discount What our report offers:
- Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Us ReportsWeb is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. Contact Us: Call: +1-646- 491-9876 Email: sales@reportsweb.com
ReportsWeb.com
Priya Sisodia
+1-646- 491-9876
sales@reportsweb.com
Source: EmailWire.Com
|